Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RARB | P10826 | 3/20 | 0.40 |
| ▸ | GPR3 | P46089 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.36 |
| ▸ | HTR2A | P28223 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | RARA | P10276 | 1/20 | 0.34 |
| ▸ | RARG | P13631 | 1/20 | 0.34 |
| ▸ | GCGR | P47871 | 1/20 | 0.34 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.34 |
| ▸ | TLR8 | Q9NR97 | 6/20 | 0.33 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17694346 | 0.99 | RARB (0.39) | RARBGPR3ESR1ESR2HTR2A | |
| SCHEMBL17694316 | 0.99 | RARB (0.42) | RARBGPR3ESR1ESR2HTR2A | |
| SCHEMBL17694324 | 0.99 | RARB (0.39) | RARBGPR3ESR1ESR2HTR2A | |
| SCHEMBL17694321 | 0.97 | RARB (0.39) | RARBGPR3ESR1ESR2HTR2A | |
| SCHEMBL17694323 | 0.92 | RARB (0.40) | RARBGPR3HTR2AKDM4ERAB9A | |
| SCHEMBL17694322 | 0.92 | RARB (0.38) | RARBGPR3ESR1ESR2HTR2A | |
| SCHEMBL16265270 | 0.91 | S1PR1 (0.39) | RARBRAB9AS1PR1 | |
| SCHEMBL17694342 | 0.91 | RARB (0.44) | RARBGPR3HTR2AKDM4ERAB9A | |
| SCHEMBL26321931 | 0.91 | ESR1 (0.38) | ESR1ESR2RAB9A | |
| SCHEMBL18464808 | 0.90 | NPC1 (0.39) | RARBESR1ESR2RAB9AGCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230053362-A1 | DICHROIC DYE COMPOSITION | MERCK PATENT GMBH (DE) | 2023-02-23 | — | — | US | disclosed |
| US-20170267929-A1 | DEVICE FOR REGULATING THE PASSAGE OF ENERGY | MERCK PATENT GMBH (DE) | 2017-09-21 | — | — | US | disclosed |
| US-20170029702-A1 | LIQUID CRYSTAL MATERIAL | MERCK PATENT GMBH (DE) | 2017-02-02 | — | — | US | disclosed |
| US-20170002203-A1 | DYE COMPOUNDS | MERCK PATENT GMBH (DE) | 2017-01-05 | — | — | US | disclosed |
| US-20160319592-A1 | DEVICE FOR REGULATING THE PASSAGE OF LIGHT | MERCK PATENT GMBH (DE) | 2016-11-03 | — | — | US | disclosed |
| US-20160108317-A1 | DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND | MERCK PATENT GMBH (DE) | 2016-04-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160108317-A1 | DEVICE FOR CONTROLLING THE PASSAGE OF ENERGY, CONTAINING A DICHROIC DYE COMPOUND | CRY1, SLC25A1, CRY2 | RARB 172/4885GPR3 2912/4885ESR1 2151/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.